Two vs three cycles of neoadjuvant immunochemotherapy for resectable non-small-cell lung cancer: a real-world population-based study

ObjectiveInvestigation of the Impact of Neoadjuvant Immunochemotherapy Cycles on Pathological Response, Perioperative Safety, and Survival Outcomes in Patients with Resectable Non-Small Cell Lung Cancer (NSCLC).MethodsThis study utilized real-world data, focusing on patients with stage IIA-IIIB non-...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Jiawei Xiu, Xin Yao, Ying Sun, Shaopeng Xu, Chao Wang, Hongtao Duan, Xiaolong Yan
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2025-11-01
Serie:	Frontiers in Immunology
Soggetti:	immunotherapy neoadjuvant immunochemotherapy (NICT) NSCLC cycle duration (time) neoadjuvant therapy
Accesso online:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1654830/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!